Intervention Protocol

You have free access to this content

Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for non-toxic multinodular goitre

  1. Chao Ma1,*,
  2. Jiawei Xie2,
  3. Suyun Chen3,
  4. Qing Su4,
  5. Hui Wang3

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 28 JUN 2013

DOI: 10.1002/14651858.CD010622


How to Cite

Ma C, Xie J, Chen S, Su Q, Wang H. Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for non-toxic multinodular goitre (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010622. DOI: 10.1002/14651858.CD010622.

Author Information

  1. 1

    Xin Hua Hospital, Shanghai Jiaotong University School of Medicine, Nuclear Medicine, Shanghai, Shanghai, China

  2. 2

    Putuo Liqun Hospital, Stomatology, Shanghai, Shanghai, China

  3. 3

    Affiliated XinHua Hospital of Medical School Shanghai Jiaotong University, Nuclear Medicine, Shanghai, Shanghai, China

  4. 4

    Xin Hua Hospital, Shanghai Jiaotong University School of Medicine, Endocrinology, Shanghai, Shanghai, China

*Chao Ma, Nuclear Medicine, Xin Hua Hospital, Shanghai Jiaotong University School of Medicine, Kongjiang Road 1665, Shanghai, Shanghai, 200092, China. mc_7419@hotmail.com. ponymachao@163.com.

Publication History

  1. Publication Status: New
  2. Published Online: 28 JUN 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of recombinant human thyrotropin (rhTSH) aided radioiodine treatment for non-toxic multinodular goitre.